This strategic filing with the FDA follows encouraging internal data and recent published studies supporting Nexalin’s ...
Nexalin Technology (NXL) announced that its Gen-2 Console, SYNC, 15 milliamp neurostimulation device has been granted regulatory approval for sale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback